{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:05:06Z","timestamp":1793754306820,"version":"4.6.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Levamisole is a common adulterant of cocaine and has been associated with reversible leukoencephalopathy in cocaine users. We report a case of two episodes with severe neurological symptoms and multifocal white matter lesions with brainstem and cerebellar involvement in a 29-year-old man after sporadic cocaine consumption. A urinalysis was positive for levamisole. Neurological deficits as well as MRI presentation improved after cessation of levamisole exposure and two courses of intravenous high-dose glucocorticoid therapy. Early diagnosis of levamisole-induced multifocal leukoencephalopathy and treatment with corticosteroids without delay is essential for a good recovery from neurological symptoms. Although cocaine is one of the most prevalent abused illicit drugs, cocaine- and levamisole-induced multifocal leukoencephalopathy is underdiagnosed as this disorder is not often described in the literature and anamnesis of drug abuse is not admitted by the patient. Therefore, an additional screening for cocaine and levamisole in clinical practice is useful in similar cases to support the diagnosis.<\/jats:p>","DOI":"10.1186\/s42466-022-00202-y","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T01:02:53Z","timestamp":1659315773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Multifocal leukoencephalopathy associated with intensive use of cocaine and the adulterant levamisole in a 29-year old patient"],"prefix":"10.1186","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2874-1148","authenticated-orcid":false,"given":"Nadine","family":"Tollens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Martins Dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Niggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Warken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"issue":"15","key":"202_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12883-015-0467-1","volume":"19","author":"R Vosoughi","year":"2015","unstructured":"Vosoughi, R., & Schmidt, B. J. (2015). Multifocal leukoencephalopathy in cocaine users: A report of two cases and review of the literature. BMC Neurology, 19(15), 208. https:\/\/doi.org\/10.1186\/s12883-015-0467-1","journal-title":"BMC Neurology"},{"issue":"3","key":"202_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.23907\/2017.039","volume":"7","author":"N Solomon","year":"2017","unstructured":"Solomon, N., & Hayes, J. (2017). Levamisole: A high performance cutting agent. Academic Forensic Pathology, 7(3), 469\u2013476. https:\/\/doi.org\/10.23907\/2017.039","journal-title":"Academic Forensic Pathology"},{"issue":"4","key":"202_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/01.md.0000230250.95281.60","volume":"85","author":"VC Wu","year":"2006","unstructured":"Wu, V. C., Huang, J. W., Lien, H. C., Hsieh, S. T., Liu, H. M., Yang, C. C., Lin, Y. H., Hwang, J. J., & Wu, K. D. (2006). Levamisole-induced multifocal inflammatory leukoencephalopathy: Clinical characteristics, outcome, and impact of treatment in 31 patients. Medicine (Baltimore), 85(4), 203\u2013213. https:\/\/doi.org\/10.1097\/01.md.0000230250.95281.60","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"202_CR4","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ana.410310306","volume":"31","author":"CC Hook","year":"1992","unstructured":"Hook, C. C., Kimmel, D. W., Kvols, L. K., Scheithauer, B. W., Forsyth, P. A., Rubin, J., Moertel, C. G., & Rodriguez, M. (1992). Multifocal inflammatory leukoencephalopathy with 5-fluorouracil and levamisole. Annals of Neurology, 31(3), 262\u2013267. https:\/\/doi.org\/10.1002\/ana.410310306","journal-title":"Annals of Neurology"},{"issue":"2","key":"202_CR5","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/FTD.0000000000000851","volume":"43","author":"KM Midthun","year":"2021","unstructured":"Midthun, K. M., Nelson, L. S., & Logan, B. K. (2021). Levamisole-a toxic adulterant in illicit drug preparations: A review. Therapeutic Drug Monitoring, 43(2), 221\u2013228. https:\/\/doi.org\/10.1097\/FTD.0000000000000851","journal-title":"Therapeutic Drug Monitoring"},{"issue":"5","key":"202_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/197140091302600503","volume":"26","author":"A Gonz\u00e1lez-Duarte","year":"2013","unstructured":"Gonz\u00e1lez-Duarte, A., & Williams, R. (2013). Cocaine-induced recurrent leukoencephalopathy. The Neuroradiology Journal, 26(5), 511\u2013513. https:\/\/doi.org\/10.1177\/197140091302600503","journal-title":"The Neuroradiology Journal"},{"issue":"4","key":"202_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1552-6569.2008.00344.x","volume":"19","author":"N Xu","year":"2009","unstructured":"Xu, N., Zhou, W., Li, S., Zhou, G., Zhang, N., & Liang, J. (2009). Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16 patients. Journal of Neuroimaging, 19(4), 326\u2013331. https:\/\/doi.org\/10.1111\/j.1552-6569.2008.00344.x","journal-title":"Journal of Neuroimaging"},{"issue":"1","key":"202_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3892\/etm.2013.1077","volume":"6","author":"R Yan","year":"2013","unstructured":"Yan, R., Wu, Q., Ren, J., Cui, H., Zhai, K., Zhai, Z., & Duan, Q. (2013). Clinical features and magnetic resonance image analysis of 15 cases of demyelinating leukoencephalopathy induced by levamisole. Experimental and Therapeutic Medicine, 6(1), 71\u201374. https:\/\/doi.org\/10.3892\/etm.2013.1077","journal-title":"Experimental and Therapeutic Medicine"},{"key":"202_CR9","doi-asserted-by":"publisher","unstructured":"Blanc, P. D., Chin, C., & Lynch, K. L. (2012). Multifocal inflammatory leukoencephalopathy associated with cocaine abuse: Is levamisole responsible? Clinical Toxicology (Philadelphia, PA) 50(6), 534\u2013535; author reply 536. https:\/\/doi.org\/10.3109\/15563650.2012.692794. Erratum in: Clinical Toxicology (Philadelphia, PA) 2012, 50(7), 723.","DOI":"10.3109\/15563650.2012.692794"},{"key":"202_CR10","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1007\/s00204-017-1947-4","volume":"91","author":"TM Brunt","year":"2017","unstructured":"Brunt, T. M., van den Berg, J., Pennings, E., & Venhuis, B. (2017). Adverse effects of levamisole in cocaine users: A review and risk assessment. Archives of Toxicology, 91, 2303\u20132313. https:\/\/doi.org\/10.1007\/s00204-017-1947-4","journal-title":"Archives of Toxicology"},{"key":"202_CR11","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/S0140-6736(04)70094-X","volume":"348","author":"P Lucia","year":"1996","unstructured":"Lucia, P., Pocek, M., Passacantando, A., Sebastiani, M. L., & De Martins, C. (1996). Multifocal leucoencephalopathy induced by levamisole. The Lancet, 348, 1450.","journal-title":"The Lancet"},{"issue":"1","key":"202_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s41398-018-0279-3","volume":"8","author":"M Vonmoos","year":"2018","unstructured":"Vonmoos, M., Hirsiger, S., Preller, K. H., Hulka, L. M., Allemann, D., Herdener, M., Baumgartner, M. R., & Quednow, B. B. (2018). Cognitive and neuroanatomical impairments associated with chronic exposure to levamisole-contaminated cocaine. Translational Psychiatry, 8(1), 235. https:\/\/doi.org\/10.1038\/s41398-018-0279-3","journal-title":"Translational Psychiatry"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-022-00202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-022-00202-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-022-00202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T01:07:58Z","timestamp":1659316078000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurolrespract.biomedcentral.com\/articles\/10.1186\/s42466-022-00202-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1186\/s42466-022-00202-y","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]},"assertion":[{"value":"19 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and clinical images was obtained from the patient. A copy of the consent from the patient is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}